Status:
COMPLETED
Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT, in a double-blind, randomized, placebo-controlled, parallel group, multi-center s...
Eligibility Criteria
Inclusion
- ≥ 20 years old
- Heart rate ≥ 70beats/min and ≤ 90beats/min at entering the CT room and just before dosing organic nitrates.
Exclusion
- Previous allergic reactions to contrast agent
- Renal failure
- Asthma
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT00924586
Start Date
June 1 2009
Last Update
June 13 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanto Region
Kanto, Japan
2
Kyushu Region
Kyushu, Japan